“…Until now, more than 20 kinds of Tg rabbits expressing different genes that are involved in lipid metabolism and atherosclerosis have been reported and studies using these Tg rabbits have provided considerable insights into the molecular mechanisms of these gene functions in lipoprotein metabolism and atherosclerosis (Fan and Watanabe, 2003 ; Peng, 2012 ; Fan et al, 2015 ). The transgenes expressed in Tg rabbits for the study of lipoprotein metabolism and atherosclerosis can generally be classified into three categories: (1) those proteins that constitute lipoprotein structures such as apo(a) (Rouy et al, 1998 ; Fan et al, 1999b ), apoAI (Duverger et al, 1996a ), apoAII (Koike et al, 2009a ; Wang et al, 2013 ), apoB-100 (Fan et al, 1995 ), apoCIII (Ding et al, 2011 ), and apoE (Huang et al, 1997 ; Fan et al, 1998 ); (2) those enzymes or transfer proteins that participate in the lipid metabolism such as hepatic lipase (Fan et al, 1994 ), lipoprotein lipase (Fan et al, 2001a ), phospholipid transfer protein (Masson et al, 2011 ), apoB-100 mRNA editing enzyme catalytic polypeptide protein (Yamanaka et al, 1995 ), lecithin:cholesterol acyltransferase (Hoeg et al, 1996 ), endothelial lipase (Wang et al, 2017 ); and (3) those proteins that may exert some functions on the arterial wall cells which participate in the pathogenesis of atherosclerosis including matrix metalloproteinase-1,9,12 (Liang et al, 2006 ; Niimi et al, 2019 ; Chen et al, 2020 ), 15-lipoxygenase (Shen et al, 1996 ), C-reactive protein (Koike et al, 2009b ), and vascular endothelial growth factor (Kitajima et al, 2005 ) ( Table 1 ). In addition, Tg rabbits have also been used for the investigation of human heart diseases, including LQT syndrome (Brunner et al, 2008 ), hypertrophic cardiomyopathy (Marian et al, 1999 ) and tachycardia-induced cardiomyopathy (Suzuki et al, 2009 ).…”